Telepsychotherapy for the Treatment of Adolescents With Trichotillomania

U

Utah State University

Status

Unknown

Conditions

Trichotillomania

Treatments

Behavioral: Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT)

Study type

Interventional

Funder types

Other

Identifiers

NCT03725163
9153 (Other Identifier)

Details and patient eligibility

About

The primary purpose of the current study is to evaluate the effectiveness of providing treatment for adolescents with trichotillomania through the use of telehealth. Parent or legal guardians' psychological flexibility scores will be assessed to determine if their levels of flexibility potentially moderate treatment outcomes. The study will test the following hypotheses: Hypothesis 1: Telepsychotherapy will result in significantly better trichotillomania symptom outcomes for adolescents than a waitlist control condition. Hypothesis 2: Telepsychotherapy will result in significantly better psychological flexibility outcomes for adolescents than a waitlist control condition. Hypothesis 3: Telepsychotherapy will result in significantly better overall wellbeing outcomes for adolescents than a waitlist control condition. Hypothesis 4: Within-group changes (that include both conditions following treatment) will be significant from pre-treatment to post-treatment and will not significantly differ from post-treatment at 3, 6, and 12-month follow-up.

Full description

The investigators of this study plan to recruit 60 participants, 30 adolescents and 30 parents or legal guardians. This number will provide adequate power (0.70) to detect a large effect size (d=.81). All portions of this study will be completed online using teleconferencing software, Zoom (similar to Skype). Participants will be randomized into either a treatment or waitlist control group. All participants will receive treatment, however, those in the waitlist group will wait 12 weeks before beginning treatment. Treatment will consist of 10, 50 minute sessions with up to six short (10-15 minute) booster sessions during a three-month period following treatment. Participants and parents/guardians will complete full assessment batteries at intake, post-waitlist (only those in the waitlist condition), post-treatment, and 3, 6, and 12 months following treatment. Moreover, adolescent participants will be asked to track their daily pulling behavior each day while in treatment(with parent/guardian help if desired). This will be done through the use of daily text message reminders using app.eztexting.com to the parent/guardian that will include a link to the short (less then 5 minute) Qualtrics survey. All treatment sessions will take place online using video conferencing software (i.e., Zoom). Parents/guardians will be invited to participate in the final 10 minutes of each session. This will allow for the adolescent to review what they have learned and also allow the parent/guardian to be involved in the fulfillment of treatment goals and to assist with skill-building throughout the week. Parents will also be give a short (1/2 to 1 page) handout following each session that will explain what was taught and how they can best help the participant make progress. Parents will also be asked to complete a short measure of psychological flexibility at intake, post-waitlist (only when applicable), post-treatment, and 3, 6, and 12-months following treatment.

Enrollment

60 estimated patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meet DSM-5 criteria for trichotillomania.
  • Seeking treatment primarily for trichotillomania-related concerns.
  • 12-17 years old.
  • Reside in Utah.
  • Speak fluent English.

Parents:

Must be fluent English speaker.

Exclusion criteria

  • Currently receiving psychotherapy.
  • Started or changed psychotropic medication in the past 30 days.
  • Planning to start or change psychotropic medication during the course of the current study.
  • Completed high school.

Trial design

60 participants in 2 patient groups

Treatment
Experimental group
Description:
This arm will begin treatment immediately after completing the initial intake assessment.
Treatment:
Behavioral: Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT)
Waitlist Control
Other group
Description:
Participants assigned to the waitlist control condition will begin a 12-week waiting period after completing the initial intake assessment before starting treatment.
Treatment:
Behavioral: Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT)

Trial contacts and locations

0

Loading...

Central trial contact

Jeremiah E Fruge, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems